Merck
CN
  • Comparison of the progression rates of the superior, inferior, and both hemifield defects in normal-tension glaucoma patients.

Comparison of the progression rates of the superior, inferior, and both hemifield defects in normal-tension glaucoma patients.

American journal of ophthalmology (2012-09-11)
Hyun-Kyung Cho, Changwon Kee
摘要

To investigate the progression rates of superior and inferior hemifield defects and each hemifield in bihemifield defects in normal-tension glaucoma patients and to compare the progression rates of each hemifield between groups in eyes with similar baseline hemifield defects. Retrospective, observational cohort study. Medical records of 142 normal-tension glaucoma patients who performed more than 5 reliable standard visual field tests with superior (group 2; n = 51), inferior (group 1; n = 44), or both hemifield (group 3; n = 47) defects were analyzed retrospectively. The changes in the mean thresholds of the 10 zones of the glaucoma hemifield test and the entire hemifield were inspected. A linear mixed effect model was used with age, gender, initial intraocular pressure, mean deviation, and pattern standard deviation controlled. There were no significant differences in age and systemic and ocular factors between groups except for female gender, which showed a significant difference among the 3 groups (P = .032). The progression rate in group 2 was significantly faster than in group 1 (-0.713 dB/year vs -0.516 dB/year; P = .019), especially in central and nasal zones or than in the superior hemifield of group 3 (-0.717 dB/year vs -0.470 dB/year; P = .001). There was no significant difference in the progression rates between group 1 and the inferior hemifield in group 3 (-0.508 dB/year vs -0.441 dB/year; P = .312) or between the superior and inferior hemifields in group 3 (-0.468 dB/year vs -0.442 dB/year; P = .662). More careful examination and caution is required in the treatment of normal-tension glaucoma patients with superior hemifield defect.

材料
货号
品牌
产品描述

Sigma-Aldrich
拉坦前列素, ≥98% (HPLC)
Sigma-Aldrich
UK 14,304